Our projects: Potential breakthroughs in the making

At Esperante Development, we relentlessly pursue new medical treatments and technologies that will benefit patient outcomes around the world.

With our new consolidation under the Sever Life Sciences Group we are committed to breakthrough treatments and novel products. We are committed to delivery of two breakthrough treatments by 2026. A common axiom in business is that “Ambition should always just exceed grasp”. We have big ambitions for our pipeline and look forward to sharing more information soon.

Therapeutic focus fields:

• Ophthalmology
• Infections
• Vertigo

LCM = Life Cicle Management
aNDA = abbreviated New Drug Application

Esperante Development is active across multiple therapies, but is currently focussed on the development of novel products, and innovative treatments and sterile products.

Esperante Development dares to be different, to be brave, to be bold…